Evidence map›Paper›PMID 26633460›Full record

ArticleViruses2015

Incomplete LPS Core-Specific Felix01-Like Virus vB_EcoM_VpaE1.

Eugenijus Šimoliūnas, Monika Vilkaitytė, Laura Kaliniene, Aurelija Zajančkauskaitė, Algirdas Kaupinis, Juozas Staniulis, Mindaugas Valius, Rolandas Meškys, Lidija Truncaitė

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. A Gifsy prophage-encoded protein confers broad phage resistance inApplied and environmental microbiology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Control ofAntibiotics (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Complete Genome Sequence ofGenome announcements · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Eugenijus ŠimoliūnasDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Vilnius University, Vilnius LT-08662, Lithuania. eugenijus.simoliunas@bchi.vu.lt.
Monika VilkaitytėDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Vilnius University, Vilnius LT-08662, Lithuania. m.vilke@gmail.com.
Laura KalinieneDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Vilnius University, Vilnius LT-08662, Lithuania. laura.kaliniene@bchi.vu.lt.
Aurelija ZajančkauskaitėDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Vilnius University, Vilnius LT-08662, Lithuania. aurelija.zajanckauskaite@bchi.vu.lt.
Algirdas KaupinisProteomics Centre, Institute of Biochemistry, Vilnius University, Vilnius LT-08662, Lithuania. algirdas.kaupinis@gf.vu.lt.
Juozas StaniulisLaboratory of Plant Viruses, Institute of Botany, Nature Research Centre, Vilnius LT-08412, Lithuania. juozas.staniulis@botanika.lt.
Mindaugas ValiusProteomics Centre, Institute of Biochemistry, Vilnius University, Vilnius LT-08662, Lithuania. mindaugas.valius@bchi.vu.lt.
Rolandas MeškysDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Vilnius University, Vilnius LT-08662, Lithuania. rolandas.meskys@bchi.vu.lt.
Lidija TruncaitėDepartment of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Vilnius University, Vilnius LT-08662, Lithuania. lidija.truncaite@bchi.vu.lt.
Vilnius University · LTNature Research Centre · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages represent a valuable source for studying the mechanisms underlying virus-host interactions. A better understanding of the host-specificity of viruses at the molecular level can promote various phage applications, including bacterial diagnostics, antimicrobial therapeutics, and improve methods in molecular biology. In this study, we describe the isolation and characterization of a novel coliphage, vB_EcoM_VpaE1, which has different host specificity than its relatives. Morphology studies, coupled with the results of genomic and proteomic analyses, indicate that vB_EcoM_VpaE1 belongs to the newly proposed genus Felix01likevirus in the family Myoviridae. The genus Felix01likevirus comprises a group of highly similar phages that infect O-antigen-expressing Salmonella and Escherichia coli (E. coli) strains. Phage vB_EcoM_VpaE1 differs from the rest of Felix01-like viruses, since it infects O-antigen-deficient E. coli strains with an incomplete core lipopolysaccharide (LPS). We show that vB_EcoM_VpaE1 can infect mutants of E. coli that contain various truncations in their LPS, and can even recognize LPS that is truncated down to the inner-core oligosaccharide, showing potential for the control of rough E. coli strains, which usually emerge as resistant mutants upon infection by O-Ag-specific phages. Furthermore, VpaE1 can replicate in a wide temperature range from 9 to 49 °C, suggesting that this virus is well adapted to harsh environmental conditions. Since the structural proteins of such phages tend to be rather robust, the receptor-recognizing proteins of VpaE1 are an attractive tool for application in glycan analysis, bacterial diagnostics and antimicrobial therapeutics.

Indexed as

Host SpecificityVirus AttachmentColiphagesEscherichia coliGenome, ViralGenomicsLipopolysaccharidesMyoviridaeO AntigensProteomeProteomicsTemperatureVirionVirus ReplicationLipopolysaccharidesO AntigensProteomebacteriophage vB_EcoM_VpaE1 host-rangeE. coli lipopolysaccharidegenus Felix01likevirusinner core oligosacharideJ0101

Identifiers

PMID26633460
PMCPMC4690856
OpenAlexW2174314873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.